CSIMarket
 


Kymera Therapeutics Inc   (KYMR)
Other Ticker:  
 
 

KYMR's Revenue Growth by Quarter and Year

Kymera Therapeutics Inc 's Revenue results by quarter and year




KYMR Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 20.34 14.53 0.00
III Quarter September 9.55 18.52 0.00 0.00
II Quarter June 11.51 18.70 0.00 0.00
I Quarter March 9.62 -14.53 0.00 0.00
FY   30.68 43.03 14.53 0.00



KYMR Revenue third quarter 2022 Y/Y Growth Comment
Kymera Therapeutics Inc reported drop in Revenue in the third quarter 2022 by -48.43% to $ 9.55 millions, from the same quarter in 2021.
The fall in the third quarter 2022 Kymera Therapeutics Inc 's Revenue compares unfavorably to the Company's average Revenue increase of 11.52%.

Looking into third quarter 2022 results within Biotechnology & Pharmaceuticals industry 75 other companies have achieved higher Revenue growth. While Kymera Therapeutics Inc ' s Revenue meltdown of -48.43% ranks overall at the positon no. 2089 in the third quarter 2022.




KYMR Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 39.99 % - -
III Quarter September -48.43 % - - -
II Quarter June -38.45 % - - -
I Quarter March - - - -
FY   - 196.15 % - -

Financial Statements
Kymera Therapeutics Inc 's third quarter 2022 Revenue $ 9.55 millions KYMR's Income Statement
Kymera Therapeutics Inc 's third quarter 2021 Revenue $ 18.52 millions Quarterly KYMR's Income Statement
New: More KYMR's historic Revenue Growth >>


KYMR Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 9.83 % - -
III Quarter September -17.02 % -0.96 % - -
II Quarter June 19.65 % - - -
I Quarter March -52.7 % - - -
FY (Year on Year)   - 196.15 % - -




Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #76
Healthcare Sector #310
Overall #2089

Revenue Y/Y Growth Statistics
High Average Low
56.14 % 11.52 % -14.95 %
(Mar 31 2022)   (Sep 30 2022)
Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #76
Healthcare Sector #310
Overall #2089
Revenue Y/Y Growth Statistics
High Average Low
56.14 % 11.52 % -14.95 %
(Mar 31 2022)   (Sep 30 2022)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Kymera Therapeutics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
19.66 % 2.86 % -17.05 %
(Jun 30 2022)  


KYMR's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2022 Kymera Therapeutics Inc disclosed fall in Revenue sequentially by -17.02% to $ 9.55 millions, from $ 11.51 millions released in the previous quarter.

When you evaluate recent shortcoming in the III. Quarter 2022, you should take into consideration, that usually III. Quarter 2022 results appear to be sluggish relative to the preciding period, Angel Das , an industry consultant added.

Within Biotechnology & Pharmaceuticals industry 68 other companies have achieved higher Revenue quarter on quarter growth. While Kymera Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 2013.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #69
Healthcare Sector #298
Overall #2013
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #69
Healthcare Sector #298
Overall #2013
Revenue Q/Q Growth Statistics
High Average Low
19.66 % 2.86 % -17.05 %
(Jun 30 2022)  


KYMR's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2022 Kymera Therapeutics Inc reported fall in Revenue from the second quarter by -17.02% to $ 9.55 millions, from $ 11.51 millions released in the previous quarter.

As we evaluate recent shortcoming at the III. Quarter, we should presume, that commonly III. Quarter Revenue emerge softer relative to the preciding period, Angel Das , an industry consultant added.

Within Biotechnology & Pharmaceuticals industry 68 other companies have achieved higher Revenue quarter on quarter growth. While Kymera Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 2013.


Kymera Therapeutics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
Cumulative Revenue 12 Months Ending $ 51.02 $ 59.99 $ 67.18 $ 43.02 $ 37.22
Y / Y Revenue Growth (TTM) 37.08 % - - - -
Year on Year Revenue Growth Overall Ranking # 433 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) -14.95 % -10.7 % 56.14 % 15.59 % -
Seq. Revenue Growth (TTM) Overall Ranking # 2089 # 3758 # 89 # 543 # 0




Cumulative Revenue growth Comment
With 37.08% annual Revenue growth, Kymera Therapeutics Inc would report a record annual Revenue rise if the fiscal year would end on Sep 30 2022.

In the Healthcare sector 74 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 433.

Revenue TTM Q/Q Growth Statistics
High Average Low
56.14 %
11.52 %
-14.95 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 76
Healthcare Sector # 75
Overall # 433

Revenue TTM Y/Y Growth Statistics
High Average Low
37.08 %
37.08 %
37.08 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 76
Sector # 310
S&P 500 # 2089
Cumulative Revenue growth Comment
With 37.08% annual Revenue growth, Kymera Therapeutics Inc would report a record annual Revenue rise if the fiscal year would end on Sep 30 2022.

In the Healthcare sector 74 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 433.

Revenue TTM Q/Q Growth Statistics
High Average Low
56.14 %
11.52 %
-14.95 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 76
Healthcare Sector # 75
Overall # 433

Revenue TTM Y/Y Growth Statistics
High Average Low
37.08 %
37.08 %
37.08 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 76
Sector # 310
S&P 500 # 2089




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
KYMR's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for KYMR's Competitors
Revenue Growth for Kymera Therapeutics Inc 's Suppliers
Revenue Growth for KYMR's Customers

You may also want to know
KYMR's Annual Growth Rates KYMR's Profitability Ratios KYMR's Asset Turnover Ratio KYMR's Dividend Growth
KYMR's Roe KYMR's Valuation Ratios KYMR's Financial Strength Ratios KYMR's Dividend Payout Ratio
KYMR's Roa KYMR's Inventory Turnover Ratio KYMR's Growth Rates KYMR's Dividend Comparisons



Companies with similar Revenue rise for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2022
Owens and Minor Inc -0.19%$ -0.191 millions
National Research Corporation-0.20%$ -0.201 millions
Livanova Plc-0.24%$ -0.241 millions
Healthcare Services Group Inc -0.27%$ -0.265 millions
Catalent Inc -0.29%$ -0.293 millions
Asensus Surgical Inc -0.31%$ -0.311 millions
Liquidia Corporation-0.43%$ -0.429 millions
Integra Lifesciences Holdings Corp-0.43%$ -0.432 millions
Pediatrix Medical Group Inc -0.62%$ -0.615 millions
China Pharma Holdings Inc -0.64%$ -0.642 millions
Acadia Pharmaceuticals Inc -0.68%$ -0.682 millions
Syneos Health Inc -0.89%$ -0.891 millions
Innovage Holding Corp -1.07%$ -1.070 millions
Procyon Corp-1.20%$ -1.200 millions
Precipio inc -1.38%$ -1.380 millions
Ati Physical Therapy Inc -1.40%$ -1.397 millions
Ocular Therapeutix Inc -1.55%$ -1.547 millions
Alpine Immune Sciences Inc -1.75%$ -1.750 millions
Surgalign Holdings Inc -1.79%$ -1.786 millions
Tenet Healthcare Corp-1.90%$ -1.900 millions
Teleflex Incorporated-1.92%$ -1.923 millions
Novocure Limited-1.95%$ -1.952 millions
Dynatronics Corporation-2.01%$ -2.014 millions
Royalty Pharma Plc-2.10%$ -2.101 millions
National Healthcare Corp-2.13%$ -2.130 millions
Fonar Corporation-2.27%$ -2.271 millions
Psychemedics Corp-2.35%$ -2.353 millions
Escalon Medical Corp -2.63%$ -2.626 millions
Lifevantage Corp-2.72%$ -2.724 millions
West Pharmaceutical Services Inc -2.77%$ -2.774 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SMFL's Profile

Stock Price

SMFL's Financials

Business Description

Fundamentals

Charts & Quotes

SMFL's News

Suppliers

SMFL's Competitors

Customers & Markets

Economic Indicators

SMFL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071